Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Adlai Nortye Eyes Global Expansion With the Opening of Its First International Site in USA 2018-08-16 22:00
Global Cord Blood Corporation to Report First Quarter Fiscal 2019 Financial Results 2018-08-16 18:00
Stealth BioTherapeutics Expands Pipeline, Advances New Compound 2018-08-15 00:00
The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease 2018-08-14 22:00
Preliminary Data from Study Demonstrates 94% Accuracy in Detecting Aggressive Prostate Cancer 2018-08-13 20:30
China Biologic Names Bing Li as New CEO 2018-08-13 20:00
JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Trastuzumab Biosimilar to Treat Breast Cancer 2018-08-10 10:05
JHL Biotech Receives Positive CHMP Scientific Advice for Global Phase III Clinical Trial of Proposed Bevacizumab Biosimilar to Treat Lung Cancer 2018-08-10 09:24
US FDA concludes review of Sugar from the first GM sugarcane variety from Centro de Tecnologia Canavieira 2018-08-10 09:00
NCCN Publishes First-Ever U.S. Guidelines for Rare Cancers Associated with Pregnancy 2018-08-09 21:15
I-Mab's Announces China Clinical Trial Approval of Long-acting hGLP-1 to Treat Type 2 Diabetes 2018-08-09 16:16
TOT BIOPHARM raises US$102 million in Series B Financing Round 2018-08-08 19:00
Eurocine Vaccines' Nasal Influenza Vaccine Candidate Immunose(TM) FLU Showed Good Safety in Older Adults 2018-08-08 15:43
VolitionRx Limited Schedules Second Quarter 2018 Earnings Conference Call and Business Update 2018-08-07 20:35
Frost & Sullivan Publishes Quarterly Update on Oramed Pharmaceuticals Inc. - Sufficient funds for clinical development activity over the next 24 months; several clinical milestones are scheduled for 2018 and 2019; as Oramed's clinical progress meets our expectations, stock target price remains at NIS 53.2. 2018-08-07 20:00
Adlai Nortye Announces Engagement of Lars E. Birgerson, M.D., Ph.D., as CDO and President/CEO of Adlai Nortye USA 2018-08-07 01:15
JNCCN -- Journal of the National Comprehensive Cancer Network Strengthens Editorial Focus on Original, Impactful Research into Cancer Care Delivery 2018-08-06 21:30
CureGenetics raises $17 million in Series A Financing 2018-08-06 21:00
AOBiome Therapeutics Announces the Expansion of its Board of Directors 2018-08-06 08:00
China Biologic Reports Financial Results for the Second Quarter of 2018 2018-08-04 04:30
1 323 324 325 326 327 440